Dissecting the roles of TRBP and PACT in double-stranded RNA recognition and processing of noncoding RNAs

Wiley Interdisciplinary Reviews: RNA

Volumn 6, Issue 3, 2015, Pages 271-289

  Heyam, Alex ^a   Lagos, Dimitris ^a   Plevin, Michael ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; DOUBLE STRANDED RNA; INTERFERON REGULATORY FACTOR 3; MICRORNA; PROTEIN ACTIVATOR OF PROTEIN KINASE R; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; RNA BINDING PROTEIN; RNA INDUCED SILENCING COMPLEX; TRANS ACTIVATION RESPONSIVE RNA BINDING PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA; CARBOXYPEPTIDASE; PRKRA PROTEIN, HUMAN; RIBONUCLEASE III; SCPEP1 PROTEIN, HUMAN; TRANS-ACTIVATION RESPONSIVE RNA-BINDING PROTEIN; VIRUS RNA;

CARBOXY TERMINAL SEQUENCE; CELL STRESS; CYTOLOGY; GENE REARRANGEMENT; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTERACTIONS WITH RNA; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; RNA PROCESSING; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CARBOXYPEPTIDASES; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE III; RNA, DOUBLE-STRANDED; RNA, UNTRANSLATED; RNA, VIRAL; RNA-BINDING PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84927911170     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1272     Document Type: Review

References (140)

1. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139. doi: 10.1038/nrm2632.
2. Gantier MP, Williams BRG. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev 2007, 18:363-371. doi: 10.1016/j.cytogfr.2007.06.016.
3. Park H, Davies MV, Langland JO, Chang HW, Nam YS, Tartaglia J, Paoletti E, Jacobs BL, Kaufman RJ, Venkatesan S. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc Natl Acad Sci U S A 1994, 91:4713-4717.
4. Patel RC, Sen GC. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 1998, 17:4379-4390. doi: 10.1093/emboj/17.15.4379.
5. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744. doi: 10.1038/nature03868.
6. Haase AD, Jaskiewicz L, Zhang H, Lainé S, Sack R, Gatignol A, Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep 2005, 6:961-967. doi: 10.1038/sj.embor.7400509.
7. Kok K-H, Lui P-Y, Ng M-HJ, Siu K-L, Au SWN, Jin D-Y. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011, 9:299-309. doi: 10.1016/j.chom.2011.03.007.
8. St Johnston D, Brown NH, Gall JG, Jantsch M. A conserved double-stranded RNA-binding domain. Proc Natl Acad Sci U S A 1992, 89:10979-10983.
9. Peters GA, Hartmann R, Qin J, Sen GC. Modular structure of PACT: distinct domains for binding and activating PKR. Mol Cell Biol 2001, 21:1908-1920. doi: 10.1128/MCB.21.6.1908-1920.2001.
10. Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J 1998, 17:5458-5465. doi: 10.1093/emboj/17.18.5458.
11. Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH-T. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 2006, 14:345-355. doi: 10.1016/j.str.2005.11.013.
12. Sohn SY, Bae WJ, Kim JJ, Yeom K-H, Kim VN, Cho Y. Crystal structure of human DGCR8 core. Nat Struct Mol Biol 2007, 14:847-853. doi: 10.1038/nsmb1294.
13. Marión RM, Fortes P, Beloso A, Dotti C, Ortín J. A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum. Mol Cell Biol 1999, 19:2212-2219.
14. Chang K-Y, Ramos A. The double-stranded RNA-binding motif, a versatile macromolecular docking platform. FEBS J 2005, 272:2109-2117. doi: 10.1111/j.1742-4658.2005.04652.x.
15. Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol 2007, 8:479-490. doi: 10.1038/nrm2178.
16. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988, 16:10881-10890. doi: 10.1093/nar/16.22.10881.
17. Gouet P. ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Res 2003, 31:3320-3323. doi: 10.1093/nar/gkg556.
18. Masliah G, Barraud P, Allain FH-T. RNA recognition by double-stranded RNA binding domains: a matter of shape and sequence. Cell Mol Life Sci 2013, 70:1875-1895. doi: 10.1007/s00018-012-1119-x.
19. Wu H, Henras A, Chanfreau G, Feigon J. Structural basis for recognition of the AGNN tetraloop RNA fold by the double-stranded RNA-binding domain of Rnt1p RNase III. Proc Natl Acad Sci U S A 2004, 101:8307-8312. doi: 10.1073/pnas.0402627101.
20. Chiliveri SC, Deshmukh MV. Structure of RDE-4 dsRBDs and mutational studies provide insights into dsRNA recognition in the Caenorhabditis elegans RNAi pathway. Biochem J 2014, 458:119-130. doi: 10.1042/BJ20131347.
21. Tabara H, Yigit E, Siomi H, Mello CC. The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans. Cell 2002, 109:861-871. doi: 10.1016/S0092-8674(02)00793-6.
22. Benoit MP, Imbert L, Palencia A, Pérard J, Ebel C, Boisbouvier J, Plevin MJ. The RNA-binding region of human TRBP interacts with microRNA precursors through two independent domains. Nucleic Acids Res 2013, 41:4241-4252. doi: 10.1093/nar/gkt086.
23. Yamashita S, Nagata T, Kawazoe M, Takemoto C, Kigawa T, Güntert P, Kobayashi N, Terada T, Shirouzu M, Wakiyama M, et al. Structures of the first and second double-stranded RNA-binding domains of human TAR RNA-binding protein. Protein Sci 2011, 20:118-130. doi: 10.1002/pro.543.
24. Parker GS, Eckert DM, Bass BL. RDE-4 preferentially binds long dsRNA and its dimerization is necessary for cleavage of dsRNA to siRNA. RNA 2006, 12:807-818. doi: 10.1261/rna.2338706.
25. Parker GS, Maity TS, Bass BL. dsRNA binding properties of RDE-4 and TRBP reflect their distinct roles in RNAi. J Mol Biol 2008, 384:967-979. doi: 10.1016/j.jmb.2008.10.002.
26. Takahashi T, Miyakawa T, Zenno S, Nishi K, Tanokura M, Ui-Tei K. Distinguishable in vitro binding mode of monomeric TRBP and dimeric PACT with siRNA. PLoS One 2013, 8:e63434. doi: 10.1371/journal.pone.0063434.
27. Gatignol A, Buckler-White A, Berkhout B, Jeang K. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 1991, 251:1597-1600. doi: 10.1126/science.2011739.
28. Dorin D, Bonnet MC, Bannwarth S, Gatignol A, Meurs EF, Vaquero C. The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J Biol Chem 2003, 278:4440-4448. doi: 10.1074/jbc.M208954200.
29. Ricci EP, Kucukural A, Cenik C, Mercier BC, Singh G, Heyer EE, Ashar-Patel A, Peng L, Moore MJ. Staufen1 senses overall transcript secondary structure to regulate translation. Nat Struct Mol Biol 2014, 21:26-35. doi: 10.1038/nsmb.2739.
30. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002, 71:817-846. doi: 10.1146/annurev.biochem.71.110601.135501.
31. Ramos A, Grünert S, Adams J, Micklem DR, Proctor MR, Freund S, Bycroft M, St Johnston D, Varani G. RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J 2000, 19:997-1009. doi: 10.1093/emboj/19.5.997.
32. Gleghorn ML, Gong C, Kielkopf CL, Maquat LE. Staufen1 dimerizes through a conserved motif and a degenerate dsRNA-binding domain to promote mRNA decay. Nat Struct Mol Biol 2013, 20:515-524. doi: 10.1038/nsmb.2528.
33. Gleghorn ML, Maquat LE. "Black sheep" that don't leave the double-stranded RNA-binding domain fold. Trends Biochem Sci 2014, 39:328-340. doi: 10.1016/j.tibs.2014.05.003.
34. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA. In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci U S A 2008, 105:512-517. doi: 10.1073/pnas.0710869105.
35. Daniels SM, Melendez-Peña CE, Scarborough RJ, Daher A, Christensen HS, El Far M, Purcell DFJ, Lainé S, Gatignol A. Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol Biol 2009, 10:38. doi: 10.1186/1471-2199-10-38.
36. Gupta V, Huang X, Patel RC. The carboxy-terminal, M3 motifs of PACT and TRBP have opposite effects on PKR activity. Virology 2003, 315:283-291. doi: 10.1016/S0042-6822(03)00589-0.
37. Lee JY, Kim H, Ryu CH, Kim JY, Choi BH, Lim Y, Huh P-W, Kim Y-H, Lee K-H, Jun T-Y, et al. Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem 2004, 279:30265-30273. doi: 10.1074/jbc.M312083200.
38. Patel RC, Stanton P, McMillan NM, Williams BR, Sen GC. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc Natl Acad Sci 1995, 92:8283-8287. doi: 10.1073/pnas.92.18.8283.
39. Poulsen H, Jorgensen R, Heding A, Nielsen FC, Bonven B, Egebjerg J. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA 2006, 12:1350-1360. doi: 10.1261/rna.2314406.
40. Zhang F, Romano PR, Nagamura-Inoue T, Tian B, Dever TE, Mathews MB, Ozato K, Hinnebusch AG. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem 2001, 276:24946-24958. doi: 10.1074/jbc.M102108200.
41. Laraki G, Clerzius G, Daher A, Melendez-Peña C, Daniels S, Gatignol A. Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol 2008, 5:92-103. doi: 10.4161/rna.5.2.6069.
42. Singh M, Castillo D, Patel CV, Patel RC. Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. Biochemistry 2011, 50:4550-4560. doi: 10.1021/bi200104h.
43. Singh M, Patel RC. Increased interaction between PACT molecules in response to stress signals is required for PKR activation. J Cell Biochem 2012, 113:2754-2764. doi: 10.1002/jcb.24152.
44. Daher A, Longuet M, Dorin D, Bois F, Segeral E, Bannwarth S, Battisti PL, Purcell DF, Benarous R, Vaquero C, et al. Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem 2001, 276:33899-33905. doi: 10.1074/jbc.M103584200.
45. Liu Q, Paroo Z. Biochemical principles of small RNA pathways. Annu Rev Biochem 2010, 79:295-319. doi: 10.1146/annurev.biochem.052208.151733.
46. Malone CD, Hannon GJ. Small RNAs as guardians of the genome. Cell 2009, 136:656-668. doi: 10.1016/j.cell.2009.01.045.
47. Gredell JA, Dittmer MJ, Wu M, Chan C, Walton SP. Recognition of siRNA asymmetry by TAR RNA binding protein. Biochemistry 2010, 49:3148-3155. doi: 10.1021/bi902189s.
48. Noland CL, Doudna JA. Multiple sensors ensure guide strand selection in human RNAi pathways. RNA 2013, 19:639-648. doi: 10.1261/rna.037424.112.
49. Yang J-S, Phillips MD, Betel D, Mu P, Ventura A, Siepel AC, Chen KC, Lai EC. Widespread regulatory activity of vertebrate microRNA* species. RNA 2011, 17:312-326. doi: 10.1261/rna.2537911.
50. Burroughs AM, Ando Y, de Hoon ML, Tomaru Y, Suzuki H, Hayashizaki Y, Daub CO. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol 2011, 8:158-177. doi: 10.4161/rna.8.1.14300.
51. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004, 15:185-197. doi: 10.1016/j.molcel.2004.07.007.
52. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640. doi: 10.1016/j.cell.2005.10.022.
53. Lee Y, Hur I, Park S-Y, Kim Y-K, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J 2006, 25:522-532. doi: 10.1038/sj.emboj.7600942.
54. Macrae IJ, Zhou K, Li F, Repic A, Brooks AN, Cande WZ, Adams PD, Doudna JA. Structural basis for double-stranded RNA processing by Dicer. Science 2006, 311:195-198. doi: 10.1126/science.1121638.
55. Chakravarthy S, Sternberg SH, Kellenberger CA, Doudna JA. Substrate-specific kinetics of dicer-catalyzed RNA processing. J Mol Biol 2010, 404:392-402. doi: 10.1016/j.jmb.2010.09.030.
56. Provost P. Ribonuclease activity and RNA binding of recombinant human Dicer. EMBO J 2002, 21:5864-5874. doi: 10.1093/emboj/cdf578.
57. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, Tomari Y. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol 2010, 17:17-23. doi: 10.1038/nsmb.1733.
58. Kawamata T, Seitz H, Tomari Y. Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol 2009, 16:953-960. doi: 10.1038/nsmb.1630.
59. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005, 65:3509-3512. doi: 10.1158/0008-5472.CAN-05-0298.
60. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009, 41:365-370. doi: 10.1038/ng.317.
61. Fu X, Xue C, Huang Y, Xie Y, Li Y. The activity and expression of microRNAs in prostate cancers. Mol Biosyst 2010, 6:2561-2572. doi: 10.1039/c0mb00100g.
62. Caramuta S, Lee L, Ozata DM, Akçakaya P, Xie H, Höög A, Zedenius J, Bäckdahl M, Larsson C, Lui W-O. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma. Endocr Relat Cancer 2013, 20:551-564. doi: 10.1530/ERC-13-0098.
63. Lin X, Wu M, Liu P, Wei F, Li L, Tang H, Xie X, Liu X, Yang L, Xie X. Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer. Med Oncol 2014, 31:868. doi: 10.1007/s12032-014-0868-9.
64. Lau P-W, Potter CS, Carragher B, MacRae IJ. Structure of the human Dicer-TRBP complex by electron microscopy. Structure 2009, 17:1326-1332. doi: 10.1016/j.str.2009.08.013.
65. Lau P-W, Guiley KZ, De N, Potter CS, Carragher B, MacRae IJ. The molecular architecture of human Dicer. Nat Struct Mol Biol 2012, 19:436-440. doi: 10.1038/nsmb.2268.
66. Wang H-W, Noland C, Siridechadilok B, Taylor DW, Ma E, Felderer K, Doudna JA, Nogales E. Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 2009, 16:1148-1153. doi: 10.1038/nsmb.1673.
67. Robb GB, Rana TM. RNA helicase A interacts with RISC in human cells and functions in RISC loading. Mol Cell 2007, 26:523-537. doi: 10.1016/j.molcel.2007.04.016.
68. Pare JM, Tahbaz N, López-Orozco J, LaPointe P, Lasko P, Hobman TC. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. Mol Biol Cell 2009, 20:3273-3284. doi: 10.1091/mbc.E09-01-0082.
69. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 2011, 108:4394-4399. doi: 10.1073/pnas.1014720108.
70. Sousa E, Graça I, Baptista T, Vieira FQ, Palmeira C, Henrique R, Jerónimo C. Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing. Epigenetics 2013, 8:548-558. doi: 10.4161/epi.24519.
71. Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog 2012, 51:916-922. doi: 10.1002/mc.20861.
72. Chiosea S, Acquafondata M, Luo J, Kuan S, Seethala R. DICER1 and PRKRA in colon adenocarcinoma. Biomark Insights 2008, 3:253-258.
73. MacRae IJ, Zhou K, Doudna JA. Structural determinants of RNA recognition and cleavage by Dicer. Nat Struct Mol Biol 2007, 14:934-940. doi: 10.1038/nsmb1293.
74. Ma E, MacRae IJ, Kirsch JF, Doudna JA. Autoinhibition of human dicer by its internal helicase domain. J Mol Biol 2008, 380:237-243. doi: 10.1016/j.jmb.2008.05.005.
75. Zhang H. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002, 21:5875-5885. doi: 10.1093/emboj/cdf582.
76. Taylor DW, Ma E, Shigematsu H, Cianfrocco MA, Noland CL, Nagayama K, Nogales E, Doudna JA, Wang H-W. Substrate-specific structural rearrangements of human Dicer. Nat Struct Mol Biol 2013, 20:9-11. doi: 10.1038/nsmb.2564.
77. Noland CL, Ma E, Doudna JA. siRNA repositioning for guide strand selection by human Dicer complexes. Mol Cell 2011, 43:110-121. doi: 10.1016/j.molcel.2011.05.028.
78. Lee HY, Doudna JA. TRBP alters human precursor microRNA processing in vitro. RNA 2012, 18:2012-2019. doi: 10.1261/rna.035501.112.
79. Lee HY, Zhou K, Smith AM, Noland CL, Doudna JA. Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing. Nucleic Acids Res 2013, 41:6568-6576. doi: 10.1093/nar/gkt361.
80. Kok K-H, Ng M-HJ, Ching Y-P, Jin D-Y. Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA. J Biol Chem 2007, 282:17649-17657. doi: 10.1074/jbc.M611768200.
81. Neilsen CT, Goodall GJ, Bracken CP. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet 2012, 28:544-549. doi: 10.1016/j.tig.2012.07.005.
82. Koscianska E, Starega-Roslan J, Krzyzosiak WJ. The role of Dicer protein partners in the processing of microRNA precursors. PLoS One 2011, 6:e28548. doi: 10.1371/journal.pone.0028548.
83. Fukunaga R, Han BW, Hung J-H, Xu J, Weng Z, Zamore PD. Dicer partner proteins tune the length of mature miRNAs in flies and mammals. Cell 2012, 151:533-546. doi: 10.1016/j.cell.2012.09.027.
84. Wang X-H, Aliyari R, Li W-X, Li H-W, Kim K, Carthew R, Atkinson P, Ding S-W. RNA interference directs innate immunity against viruses in adult Drosophila. Science 2006, 312:452-454. doi: 10.1126/science.1125694.
85. Ghildiyal M, Seitz H, Horwich MD, Li C, Du T, Lee S, Xu J, Kittler ELW, Zapp ML, Weng Z, et al. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science 2008, 320:1077-1081. doi: 10.1126/science.1157396.
86. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 2004, 117:69-81.
87. Liu Q, Rand TA, Kalidas S, Du F, Kim H-E, Smith DP, Wang X. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 2003, 301:1921-1925. doi: 10.1126/science.1088710.
88. Tomari Y, Matranga C, Haley B, Martinez N, Zamore PD. A protein sensor for siRNA asymmetry. Science 2004, 306:1377-1380. doi: 10.1126/science.1102755.
89. Saito K, Ishizuka A, Siomi H, Siomi MC. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells. PLoS Biol 2005, 3:e235. doi: 10.1371/journal.pbio.0030235.
90. Jiang F, Ye X, Liu X, Fincher L, McKearin D, Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev 2005, 19:1674-1679. doi: 10.1101/gad.1334005.
91. Hartig JV, Esslinger S, Böttcher R, Saito K, Förstemann K. Endo-siRNAs depend on a new isoform of loquacious and target artificially introduced, high-copy sequences. EMBO J 2009, 28:2932-2944. doi: 10.1038/emboj.2009.220.
92. Marques JT, Kim K, Wu P-H, Alleyne TM, Jafari N, Carthew RW. Loqs and R2D2 act sequentially in the siRNA pathway in Drosophila. Nat Struct Mol Biol 2010, 17:24-30. doi: 10.1038/nsmb.1735.
93. Förstemann K, Tomari Y, Du T, Vagin VV, Denli AM, Bratu DP, Klattenhoff C, Theurkauf WE, Zamore PD. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol 2005, 3:e236. doi: 10.1371/journal.pbio.0030236.
94. Park JK, Liu X, Strauss TJ, McKearin DM, Liu Q. The miRNA pathway intrinsically controls self-renewal of Drosophila germline stem cells. Curr Biol 2007, 17:533-538. doi: 10.1016/j.cub.2007.01.060.
95. Bennett RL, Blalock WL, Choi E-J, Lee YJ, Zhang Y, Zhou L, Oh SP, May WS. RAX is required for fly neuronal development and mouse embryogenesis. Mech Dev 2008, 125:777-785. doi: 10.1016/j.mod.2008.06.009.
96. Koh HR, Kidwell MA, Ragunathan K, Doudna JA, Myong S. ATP-independent diffusion of double-stranded RNA binding proteins. Proc Natl Acad Sci U S A 2013, 110:151-156. doi: 10.1073/pnas.1212917110.
97. Paroo Z, Ye X, Chen S, Liu Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 2009, 139:112-122. doi: 10.1016/j.cell.2009.06.044.
98. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823. doi: 10.1126/science.1231143.
99. Ohrt T, Muetze J, Svoboda P, Schwille P. Intracellular localization and routing of miRNA and RNAi pathway components. Curr Top Med Chem 2012, 12:79-88. doi: 10.2174/156802612798919132.
100. Ohrt T, Mütze J, Staroske W, Weinmann L, Höck J, Crell K, Meister G, Schwille P. Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells. Nucleic Acids Res 2008, 36:6439-6449. doi: 10.1093/nar/gkn693.
101. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA, Pasquinelli AE, Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007, 447:823-828. doi: 10.1038/nature05841.
102. Stalder L, Heusermann W, Sokol L, Trojer D, Wirz J, Hean J, Fritzsche A, Aeschimann F, Pfanzagl V, Basselet P, et al. The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. EMBO J 2013, 32:1115-1127. doi: 10.1038/emboj.2013.52.
103. Kim YJ, Maizel A, Chen X. Traffic into silence: endomembranes and post-transcriptional RNA silencing. EMBO J 2014, 33:968-980. doi: 10.1002/embj.201387262.
104. Schlee M, Hartmann G. The chase for the RIG-I ligand-recent advances. Mol Ther 2010, 18:1254-1262. doi: 10.1038/mt.2010.90.
105. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435. doi: 10.1016/j.cell.2011.09.039.
106. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422. doi: 10.1016/j.cell.2011.09.023.
107. Kolakofsky D, Kowalinski E, Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127. doi: 10.1261/rna.035949.112.
108. Yoneyama M, Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 2009, 227:54-65. doi: 10.1111/j.1600-065X.2008.00727.x.
109. Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22. doi: 10.1016/j.coi.2008.01.002.
110. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013, 14:74-84. doi: 10.1016/j.chom.2013.06.010.
111. Siu K-L, Yeung ML, Kok K-H, Yuen K-S, Kew C, Lui P-Y, Chan C-P, Tse H, Woo PCY, Yuen K-Y, et al. Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. J Virol 2014, 88:4866-4876. doi: 10.1128/JVI.03649-13.
112. Fairman-Williams ME, Guenther U-P, Jankowsky E. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol 2010, 20:313-324. doi: 10.1016/j.sbi.2010.03.011.
113. Iwamura T, Yoneyama M, Koizumi N, Okabe Y, Namiki H, Samuel CE, Fujita T. PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus. Biochem Biophys Res Commun 2001, 282:515-523. doi: 10.1006/bbrc.2001.4606.
114. Peters GA, Khoo D, Mohr I, Sen GC. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J Virol 2002, 76:11054-11064. doi: 10.1128/JVI.76.21.11054-11064.2002.
115. Kew C, Lui P-Y, Chan C-P, Liu X, Au SWN, Mohr I, Jin D-Y, Kok K-H. Suppression of PACT-induced type I interferon production by herpes simplex virus 1 Us11 protein. J Virol 2013, 87:13141-13149. doi: 10.1128/JVI.02564-13.
116. Fabozzi G, Nabel CS, Dolan MA, Sullivan NJ. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J Virol 2011, 85:2512-2523. doi: 10.1128/JVI.01160-10.
117. Tafforeau L, Chantier T, Pradezynski F, Pellet J, Mangeot PE, Vidalain P-O, Andre P, Rabourdin-Combe C, Lotteau V. Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. J Virol 2011, 85:13010-13018. doi: 10.1128/JVI.02651-10.
118. Bennasser Y, Yeung ML, Jeang K-T. HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 2006, 281:27674-27678. doi: 10.1074/jbc.C600072200.
119. Sanghvi VR, Steel LF. The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. J Virol 2011, 85:12614-12621. doi: 10.1128/JVI.05240-11.
120. Sanghvi VR, Steel LF. A re-examination of global suppression of RNA interference by HIV-1. PLoS One 2011, 6:e17246. doi: 10.1371/journal.pone.0017246.
121. Marques JT, White CL, Peters GA, Williams BRG, Sen GC. The role of PACT in mediating gene induction, PKR activation, and apoptosis in response to diverse stimuli. J Interferon Cytokine Res 2008, 28:469-476. doi: 10.1089/jir.2007.0006.
122. Donnelly N, Gorman AM, Gupta S, Samali A. The eIF2α kinases: their structures and functions. Cell Mol Life Sci 2013, 70:3493-3511. doi: 10.1007/s00018-012-1252-6.
123. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62:379-390.
124. Cole JL. Activation of PKR: an open and shut case? Trends Biochem Sci 2007, 32:57-62. doi: 10.1016/j.tibs.2006.12.003.
125. Vattem KM, Staschke KA, Wek RC. Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR. Eur J Biochem 2001, 268:3674-3684. doi: 10.1046/j.1432-1327.2001.02273.x.
126. García MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007, 89:799-811. doi: 10.1016/j.biochi.2007.03.001.
127. Peters GA, Li S, Sen GC. Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J Biol Chem 2006, 281:35129-35136. doi: 10.1074/jbc.M607714200.
128. Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A, Jeang KT. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 1997, 16:611-624. doi: 10.1093/emboj/16.3.611.
129. Cosentino GP, Venkatesan S, Serluca FC, Green SR, Mathews MB, Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci U S A 1995, 92:9445-9449.
130. Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC. Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci U S A 2006, 103:10005-10010. doi: 10.1073/pnas.0602317103.
131. Daher A, Laraki G, Singh M, Melendez-Peña CE, Bannwarth S, Peters AH, Meurs EF, Braun RE, Patel RC, Gatignol A. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol Cell Biol 2009, 29:254-265. doi: 10.1128/MCB.01030-08.
132. Huang X, Hutchins B, Patel RC. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem J 2002, 366:175-186. doi: 10.1042/BJ20020204.
133. Li S, Sen GC. PACT-mediated enhancement of reporter gene expression at the translational level. J Interferon Cytokine Res 2003, 23:689-697. doi: 10.1089/107999003772084806.
134. Peters GA, Dickerman B, Sen GC. Biochemical analysis of PKR activation by PACT. Biochemistry 2009, 48:7441-7447. doi: 10.1021/bi900433y.
135. Cullen BR. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 2006, 7:563-567. doi: 10.1038/ni1352.
136. Ulvila J, Hultmark D, Rämet M. RNA silencing in the antiviral innate immune defence-role of DEAD-box RNA helicases. Scand J Immunol 2010, 71:146-158. doi: 10.1111/j.1365-3083.2009.02362.x.
137. Rowe TM, Rizzi M, Hirose K, Peters GA, Sen GC. A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc Natl Acad Sci U S A 2006, 103:5823-5828. doi: 10.1073/pnas.0601287103.
138. Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 2008, 7:207-215. doi: 10.1016/S1474-4422(08)70022-X.
139. Kim Y, Yeo J, Lee JH, Cho J, Seo D, Kim J-S, Kim VN. Deletion of human tarbp2 reveals cellular microRNA targets and cell-cycle function of TRBP. Cell Rep 2014, 9:1061-1074.
140. Wilson RC, Tambe A, Kidwell MA, Noland CL, Schneider CP, Doudna JA. Dicer-TRBP complex formation ensures accurate mammalian MicroRNA biogenesis. Mol Cell 2015. doi: 10.1016/j.molcel.2014.11.030.